Skip to main content
Erschienen in: Strahlentherapie und Onkologie 7/2015

01.07.2015 | Original Article

Information preferences regarding cure rates and prognosis of Austrian patients with advanced lung cancer

verfasst von: Tamara Rumpold, M.Sc., Carola Lütgendorf-Caucig, M.D., Reinhold Jagsch, M.Sc., Ph.D., Prof. Karin Dieckmann, M.D., Prof. Herbert Watzke, M.D., Prof. Richard Pötter, M.D., Kathrin Kirchheiner, M.Sc., Ph.D.

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Due to concerns about patients’ wellbeing, open end-of-life communication is associated with reservation. Furthermore, sociocultural differences must be considered. The objective of this pilot study was therefore to investigate the information preferences of Austrian patients regarding cure rates and prognosis.

Patients and methods

The information preferences of 50 advanced lung cancer patients were assessed at their first visit to the Department of Radiation Oncology, Medical University of Vienna. Preferences in terms of content (cure rates and/or prognosis) and depth of the information (additional quantitative estimates) were addressed. After the individually adapted medical consultation, patients’ satisfaction with the consultation and the emotional responses to the information were evaluated.

Results

The majority of patients (76 %) requested information about cure rates and/or prognosis; nearly half of these (47 %) wanted additional quantitative estimates. Neither sociodemographic variables, disease characteristics, nor time since diagnosis had an impact on the information preferences. The individually adapted medical information showed no overall negative influence on the emotional responses; only patients receiving prognostic information had significantly higher distress scores after the consultation. High satisfaction with the individually adapted medical consultation was reported by 92 % of patients.

Conclusion

Austrian physicians may offer end-of-life communication and directly ask patients about their information preferences, since patients seem able to decide whether or not prognostic information would overwhelm their emotional capacity and therefore to accept or reject the invitation. The disclosure of cure rates and/or prognosis with or without quantitative estimates—according to the patients’ preferences—shows overall no negative impact on emotional reactions. The individually adapted consultation results in high patient satisfaction. Nevertheless, prognostic information may lead to higher distress.
Literatur
1.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
2.
Zurück zum Zitat Baile WF, Lenzi R, Parker P et al (2002) Oncologists’ attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol 20:2189–2196PubMedCrossRef Baile WF, Lenzi R, Parker P et al (2002) Oncologists’ attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol 20:2189–2196PubMedCrossRef
4.
Zurück zum Zitat Butow PN, Maclean M (1997) The dynamics of change: cancer patients’ preferences for information, involvement and support. Ann Oncol 8:857–863PubMedCrossRef Butow PN, Maclean M (1997) The dynamics of change: cancer patients’ preferences for information, involvement and support. Ann Oncol 8:857–863PubMedCrossRef
5.
Zurück zum Zitat Charles C, Gafni A, Whelan T (1997) Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 44:681–692PubMedCrossRef Charles C, Gafni A, Whelan T (1997) Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 44:681–692PubMedCrossRef
6.
Zurück zum Zitat Chochinov HM, Tataryn DJ, Wilson KG et al (2000) Prognostic awareness and the terminally ill. Psychosomatics. 41:500–504PubMedCrossRef Chochinov HM, Tataryn DJ, Wilson KG et al (2000) Prognostic awareness and the terminally ill. Psychosomatics. 41:500–504PubMedCrossRef
7.
Zurück zum Zitat Christakis N, Iwashyna TJ (1998) Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med 158:2389–2395PubMedCrossRef Christakis N, Iwashyna TJ (1998) Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med 158:2389–2395PubMedCrossRef
8.
Zurück zum Zitat Clayton JM, Hancock KM, Butow PN et al (2007) Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust 186:77–108 Clayton JM, Hancock KM, Butow PN et al (2007) Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust 186:77–108
10.
Zurück zum Zitat Fallowfield LJ, Jenkins VA, Beveridge HA (2002) Truth may hurt but deceit hurts more: communication in palliative care. Palliat Med 16:297–303PubMedCrossRef Fallowfield LJ, Jenkins VA, Beveridge HA (2002) Truth may hurt but deceit hurts more: communication in palliative care. Palliat Med 16:297–303PubMedCrossRef
11.
Zurück zum Zitat Fayers PM, Aaronson NK, Bjordal K et al (2001) The EORTC QLQ-C30 scoring manual European Organization for Research and treatment of cancer. Brussels Fayers PM, Aaronson NK, Bjordal K et al (2001) The EORTC QLQ-C30 scoring manual European Organization for Research and treatment of cancer. Brussels
12.
Zurück zum Zitat Field A (2009) Discovering statistics using SPSS. Sage Publications, London Field A (2009) Discovering statistics using SPSS. Sage Publications, London
13.
Zurück zum Zitat Gaissmaier W, Gigerenzer G (2011) When misinformed patients try to make informed health decisions. In: Gigerenzer G, Muir Gray JA (eds). Better doctors, better patients, better decisions: envisioning health care 2020. MIT Press, Cambridge, p. 29–44 Gaissmaier W, Gigerenzer G (2011) When misinformed patients try to make informed health decisions. In: Gigerenzer G, Muir Gray JA (eds). Better doctors, better patients, better decisions: envisioning health care 2020. MIT Press, Cambridge, p. 29–44
14.
Zurück zum Zitat Gattellari M, Butow PN, Tattersall MHN et al (1999) Misunderstanding in cancer patients: why shoot the messenger? Ann Oncol 10:39–46PubMedCrossRef Gattellari M, Butow PN, Tattersall MHN et al (1999) Misunderstanding in cancer patients: why shoot the messenger? Ann Oncol 10:39–46PubMedCrossRef
15.
Zurück zum Zitat Georgaki S, Kalaidopoulou O, Liarmakopoulos I et al (2002) Nurses’ attitudes toward truthful communication with patients with cancer. A Greek study. Cancer Nurs 25:436–441PubMedCrossRef Georgaki S, Kalaidopoulou O, Liarmakopoulos I et al (2002) Nurses’ attitudes toward truthful communication with patients with cancer. A Greek study. Cancer Nurs 25:436–441PubMedCrossRef
16.
Zurück zum Zitat Hagerty RG, Butow PN, Ellis PA et al (2004) Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol 22:1721–1730PubMedCrossRef Hagerty RG, Butow PN, Ellis PA et al (2004) Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol 22:1721–1730PubMedCrossRef
17.
Zurück zum Zitat Helft PR (2005) Necessary collusion: Prognostic communication with advanced cancer patients. J Clin Oncol 23:3146–3150PubMedCrossRef Helft PR (2005) Necessary collusion: Prognostic communication with advanced cancer patients. J Clin Oncol 23:3146–3150PubMedCrossRef
18.
Zurück zum Zitat Huang X, Butow PN, Meiser B et al (1999) Attitudes and information needs of Chinese migrant cancer patients and their relatives. Aust N Z J Med 29:207–213PubMedCrossRef Huang X, Butow PN, Meiser B et al (1999) Attitudes and information needs of Chinese migrant cancer patients and their relatives. Aust N Z J Med 29:207–213PubMedCrossRef
19.
Zurück zum Zitat Iconomou G, Viha A, Koutra A et al (2002) Information needs and awareness of diagnosis in patients with cancer receiving chemotherapy: a report from Greece. Palliat Med 16:315–321PubMedCrossRef Iconomou G, Viha A, Koutra A et al (2002) Information needs and awareness of diagnosis in patients with cancer receiving chemotherapy: a report from Greece. Palliat Med 16:315–321PubMedCrossRef
20.
Zurück zum Zitat Kaplowitz SA, Campo S, Chiu WT (2002) Cancer patients’ desires for communication of prognosis information. Health Commun 14:221–241PubMedCrossRef Kaplowitz SA, Campo S, Chiu WT (2002) Cancer patients’ desires for communication of prognosis information. Health Commun 14:221–241PubMedCrossRef
21.
Zurück zum Zitat Krasner MS, Epstein RM, Beckman H et al (2009) Association of an educational program in mindful communication with burnout, empathy, and attitudes among primary care physicians. J Am Med Assoc 302:1284–1293CrossRef Krasner MS, Epstein RM, Beckman H et al (2009) Association of an educational program in mindful communication with burnout, empathy, and attitudes among primary care physicians. J Am Med Assoc 302:1284–1293CrossRef
22.
Zurück zum Zitat Laine C, Davidoff F (1996) Patient-centered medicine: a professional evolution. J Am Med Assoc 275:152–156CrossRef Laine C, Davidoff F (1996) Patient-centered medicine: a professional evolution. J Am Med Assoc 275:152–156CrossRef
23.
Zurück zum Zitat Mack JW, Smith TJ (2012) Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. J Clin Oncol 30:2715–2717PubMedCrossRef Mack JW, Smith TJ (2012) Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. J Clin Oncol 30:2715–2717PubMedCrossRef
24.
Zurück zum Zitat Mystakidou K, Parpa E, Tsilila E et al (2004) Cancer information disclosure in different cultural contexts. Support Care Cancer 12:147–154PubMedCrossRef Mystakidou K, Parpa E, Tsilila E et al (2004) Cancer information disclosure in different cultural contexts. Support Care Cancer 12:147–154PubMedCrossRef
25.
Zurück zum Zitat Ngo-Metzger Q, August KJ, Srinivasan M et al (2008) End-of-life care: guidelines for patient-centered communication. Am Fam Physician 77:167–74PubMed Ngo-Metzger Q, August KJ, Srinivasan M et al (2008) End-of-life care: guidelines for patient-centered communication. Am Fam Physician 77:167–74PubMed
26.
Zurück zum Zitat Pieterse AH, Jager N, Smets EM et al (2013) Lay understanding of common medical terminology in oncology. Psychooncology 22:1186–1191PubMedCrossRef Pieterse AH, Jager N, Smets EM et al (2013) Lay understanding of common medical terminology in oncology. Psychooncology 22:1186–1191PubMedCrossRef
27.
Zurück zum Zitat Republik Österreich (2006) BGBl I 2006/42 Republik Österreich (2006) BGBl I 2006/42
28.
Zurück zum Zitat Schofield PE, Butow PN, Thompson JF et al (2003) Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol 14:48–56PubMedCrossRef Schofield PE, Butow PN, Thompson JF et al (2003) Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol 14:48–56PubMedCrossRef
29.
Zurück zum Zitat Surbone A (2008) Cultural aspects of communication in cancer care. Support Care Cancer 16:235–240PubMedCrossRef Surbone A (2008) Cultural aspects of communication in cancer care. Support Care Cancer 16:235–240PubMedCrossRef
30.
Zurück zum Zitat Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742PubMedCrossRef Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742PubMedCrossRef
31.
Zurück zum Zitat The AM, Hak T, Koëter G et al (2001) Collusion in doctor-patient communication about imminent death: an ethnographic study. West J Med 174:247–53PubMedCentralPubMedCrossRef The AM, Hak T, Koëter G et al (2001) Collusion in doctor-patient communication about imminent death: an ethnographic study. West J Med 174:247–53PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Uchitomi Y, Yamawaki S (1997) Truth-telling practice in cancer care in Japan. Ann N Y Acad Sci 809:290–299PubMedCrossRef Uchitomi Y, Yamawaki S (1997) Truth-telling practice in cancer care in Japan. Ann N Y Acad Sci 809:290–299PubMedCrossRef
33.
Zurück zum Zitat Vandekieft GK (2001) Breaking bad news. Am Fam Physician 64:1975–1978PubMed Vandekieft GK (2001) Breaking bad news. Am Fam Physician 64:1975–1978PubMed
Metadaten
Titel
Information preferences regarding cure rates and prognosis of Austrian patients with advanced lung cancer
verfasst von
Tamara Rumpold, M.Sc.
Carola Lütgendorf-Caucig, M.D.
Reinhold Jagsch, M.Sc., Ph.D.
Prof. Karin Dieckmann, M.D.
Prof. Herbert Watzke, M.D.
Prof. Richard Pötter, M.D.
Kathrin Kirchheiner, M.Sc., Ph.D.
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 7/2015
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-015-0816-4

Weitere Artikel der Ausgabe 7/2015

Strahlentherapie und Onkologie 7/2015 Zur Ausgabe

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.